Lataa...
Safety of lamivudine treatment for chronic hepatitis B in early pregnancy
AIM: To evaluate the safety of lamivudine (LAM) treatment for chronic hepatitis B in early pregnancy. METHODS: A total of 92 pregnant women who received LAM treatment either before pregnancy or in early pregnancy were enrolled in this study. All of the pregnant women volunteered to take lamivudine d...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Baishideng Publishing Group Co., Limited
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3516809/ https://ncbi.nlm.nih.gov/pubmed/23236240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v18.i45.6645 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|